
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
ABSTRACT Adult and child B-cell progenitor acute lymphoblastic leukemia (BCP-ALL) differ in terms of incidence and prognosis. These disparities are mainly due to the molecular abnormalities
associated with these two clinical entities. A genome-wide analysis using oligo SNP arrays recently demonstrated that _PAX5_ (paired-box domain 5) is the main target of somatic mutations in
childhood BCP-ALL being altered in 38.9% of the cases. We report here the most extensive analysis of alterations of _PAX5_ coding sequence in 117 adult BCP-ALL patients in the unique
clinical protocol GRAALL-2003/GRAAPH-2003. Our study demonstrates that _PAX5_ is mutated in 34% of adult BCP-ALL, mutations being partial or complete deletion, partial or complete
amplification, point mutation or fusion gene. _PAX5_ alterations are heterogeneous consisting in complete loss in 17%, focal deletions in 10%, point mutations in 7% and translocations in 1%
of the cases. _PAX5_ complete loss and _PAX5_ point mutations differ. _PAX5_ complete loss seems to be a secondary event and is significantly associated with _BCR-ABL1_ or _TCF3-PBX1_ fusion
genes and a lower white blood cell count. Access through your institution Buy or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access
through your institution Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink *
Instant access to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional
subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY OTHERS HETEROGENEITY OF _IKZF1_ GENOMIC ALTERATIONS AND RISK OF RELAPSE IN CHILDHOOD B-CELL PRECURSOR
ACUTE LYMPHOBLASTIC LEUKEMIA Article 13 May 2025 INTEGRATIVE GENOMIC ANALYSIS OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKAEMIA LACKING A GENETIC BIOMARKER IN THE UKALL2003 CLINICAL TRIAL Article
Open access 22 December 2022 PROGNOSTIC IMPACT OF CHROMOSOMAL ABNORMALITIES AND COPY NUMBER ALTERATIONS IN ADULT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKAEMIA: A UKALL14 STUDY Article Open
access 16 October 2021 REFERENCES * Cobaleda C, Schebesta A, Delogu A, Busslinger M . Pax5: the guardian of B cell identity and function. _Nat Immunol_ 2007; 8: 463–470. Article CAS Google
Scholar * Robson EJ, He SJ, Eccles MR . A PANorama of _PAX_ genes in cancer and development. _Nat Rev Cancer_ 2006; 6: 52–62. Article CAS Google Scholar * Adams B, Dorfler P, Aguzzi A,
Kozmik Z, Urbanek P, Maurer-Fogy I _et al_. Pax-5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. _Genes Dev_ 1992; 6:
1589–1607. Article CAS Google Scholar * Fuxa M, Busslinger M . Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of pax5 in support of its B cell identity
function. _J Immunol_ 2007; 178: 3031–3037. Article CAS Google Scholar * Nutt SL, Heavey B, Rolink AG, Busslinger M . Commitment to the B-lymphoid lineage depends on the transcription
factor Pax5. _Nature_ 1999; 401: 556–562. Article CAS Google Scholar * Rolink AG, Nutt SL, Melchers F, Busslinger M . Long-term _in vivo_ reconstitution of T-cell development by
Pax5-deficient B-cell progenitors. _Nature_ 1999; 401: 603–606. Article CAS Google Scholar * Cobaleda C, Jochum W, Busslinger M . Conversion of mature B cells into T cells by
dedifferentiation to uncommitted progenitors. _Nature_ 2007; 449: 473–477. Article CAS Google Scholar * Iida S, Rao PH, Nallasivam P, Hibshoosh H, Butler M, Louie DC _et al_. The
t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene. _Blood_ 1996; 88: 4110–4117. CAS PubMed Google Scholar * Busslinger M, Klix
N, Pfeffer P, Graninger PG, Kozmik Z . Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell
lymphoma. _Proc Natl Acad Sci USA_ 1996; 93: 6129–6134. Article CAS Google Scholar * Poppe B, De Paepe P, Michaux L, Dastugue N, Bastard C, Herens C _et al_. PAX5/IGH rearrangement is a
recurrent finding in a subset of aggressive B-NHL with complex chromosomal rearrangements. _Genes Chromosomes Cancer_ 2005; 44: 218–223. Article CAS Google Scholar * Cazzaniga G, Daniotti
M, Tosi S, Giudici G, Aloisi A, Pogliani E _et al_. The paired box domain gene PAX5 is fused to ETV6/TEL in an acute lymphoblastic leukemia case. _Cancer Res_ 2001; 61: 4666–4670. CAS
PubMed Google Scholar * Mullighan CG, Goorha S, Radtke I, Miller CB, Coustan-Smith E, Dalton JD _et al_. Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia.
_Nature_ 2007; 446: 758–764. Article CAS Google Scholar * Kawamata N, Ogawa S, Zimmermann M, Niebuhr B, Stocking C, Sanada M _et al_. Cloning of genes involved in chromosomal
translocations by high-resolution single nucleotide polymorphism genomic microarray. _Proc Natl Acad Sci USA_ 2008; 105: 11921–11926. Article CAS Google Scholar * Nebral K, Denk D,
Attarbaschi A, Konig M, Mann G, Haas OA _et al_. Incidence and diversity of PAX5 fusion genes in childhood acute lymphoblastic leukemia. _Leukemia_ 2009; 23: 134–143. Article CAS Google
Scholar * An Q, Wright SL, Konn ZJ, Matheson E, Minto L, Moorman AV _et al_. Variable breakpoints target PAX5 in patients with dicentric chromosomes: a model for the basis of unbalanced
translocations in cancer. _Proc Natl Acad Sci USA_ 2008; 105: 17050–17054. Article CAS Google Scholar * Bousquet M, Broccardo C, Quelen C, Meggetto F, Kuhlein E, Delsol G _et al_. A novel
PAX5-ELN fusion protein identified in B-cell acute lymphoblastic leukemia acts as a dominant negative on wild-type PAX5. _Blood_ 2007; 109: 3417–3423. Article CAS Google Scholar * Nebral
K, Konig M, Harder L, Siebert R, Haas OA, Strehl S . Identification of PML as novel PAX5 fusion partner in childhood acute lymphoblastic leukaemia. _Br J Haematol_ 2007; 139: 269–274.
Article CAS Google Scholar * Armstrong SA, Look AT . Molecular genetics of acute lymphoblastic leukemia. _J Clin Oncol_ 2005; 23: 6306–6315. Article CAS Google Scholar * Huguet F,
Leguay T, Raffoux E, Thomas X, Beldjord K, Delabesse E _et al_. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003
Study. _J Clin Oncol_ 2009; 27: 911–918. Article CAS Google Scholar * de Labarthe A, Rousselot P, Huguet-Rigal F, Delabesse E, Witz F, Maury S _et al_. Imatinib combined with induction or
consolidation chemotherapy in patients with _de novo_ Philadelphia chromosome-positive acute lymphoblastic leukemia: results of the GRAAPH-2003 study. _Blood_ 2007; 109: 1408–1413. Article
CAS Google Scholar * Heerema NA, Raimondi SC, Anderson JR, Biegel J, Camitta BM, Cooley LD _et al_. Specific extra chromosomes occur in a modal number dependent pattern in pediatric
acute lymphoblastic leukemia. _Genes Chromosomes Cancer_ 2007; 46: 684–693. Article CAS Google Scholar * van Dongen JJ, Langerak AW, Bruggemann M, Evans PA, Hummel M, Lavender FL _et al_.
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the
BIOMED-2 Concerted Action BMH4-CT98-3936. _Leukemia_ 2003; 17: 2257–2317. Article CAS Google Scholar * Kaplan E, Meier P . Nonparametric estimation from incomplete observations. _J Am
stat Assoc_ 1958; 53: 457–481. Article Google Scholar * Peto R, Peto J . Asymptotically efficient rank invariant test procedures. _J R Stat Soc_ 1972; 135: 185–206. Google Scholar * Gray
R . A class of _k_-sample tests for comparing the cumulative incidence of a competing risk. _Ann Stat_ 1998; 16: 1141–1154. Article Google Scholar * Kozmik Z, Wang S, Dorfler P, Adams B,
Busslinger M . The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP. _Mol Cell Biol_ 1992; 12: 2662–2672. Article CAS Google Scholar * Pui CH, Behm
FG, Downing JR, Hancock ML, Shurtleff SA, Ribeiro RC _et al_ 11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia. _J Clin Oncol_ 1994; 12: 909–915.
Article CAS Google Scholar * Bene MC, Castoldi G, Knapp W, Ludwig WD, Matutes E, Orfao A _et al_. Proposals for the immunological classification of acute leukemias. European Group for the
Immunological Characterization of Leukemias (EGIL). _Leukemia_ 1995; 9: 1783–1786. CAS PubMed Google Scholar * Bertolino E, Reddy K, Medina KL, Parganas E, Ihle J, Singh H . Regulation
of interleukin 7-dependent immunoglobulin heavy-chain variable gene rearrangements by transcription factor STAT5. _Nat Immunol_ 2005; 6: 836–843. Article CAS Google Scholar * Paulsson K,
Cazier JB, Macdougall F, Stevens J, Stasevich I, Vrcelj N _et al_. Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: unexpected similarities with
pediatric disease. _Proc Natl Acad Sci USA_ 2008; 105: 6708–6713. Article CAS Google Scholar * Mullighan CG, Miller CB, Radtke I, Phillips LA, Dalton J, Ma J _et al_. BCR-ABL1
lymphoblastic leukaemia is characterized by the deletion of Ikaros. _Nature_ 2008; 453: 110–114. Article CAS Google Scholar * Miller CS, Mullighan CG, Su X, Ma J, Wang M, Zhang J _et al_.
Pax5 haploinsufficiency cooperates with BCR-ABL1 to induce acute lymphoblastic leukemia. _Blood_ 2008; 112: 114. Article Google Scholar * Mortuza FY, Moreira IM, Papaioannou M, Gameiro P,
Coyle LA, Gricks CS _et al_. Immunoglobulin heavy-chain gene rearrangement in adult acute lymphoblastic leukemia reveals preferential usage of J(H)-proximal variable gene segments. _Blood_
2001; 97: 2716–2726. Article CAS Google Scholar * Nutt SL, Urbanek P, Rolink A, Busslinger M . Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and
adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus. _Genes Dev_ 1997; 11: 476–491. Article CAS Google Scholar Download references ACKNOWLEDGEMENTS We thank the
financial support of the association Laurette-Fugain. JF was supported by an ARC fellowship. CB and NPH were supported by a grant of Institut National du Cancer. ED, CB and PB were supported
by the CITTIL (Cooperacion de investigacion transpirenaica en la terapia innovadora de la leucemia). This work would not have been possible without the help of all the people who take care
of the patients involved in the GRAALL studies, especially the centers that contributed directly to this study. Amiens: Damaj, Royer, Dubus, Capiod, Marolleau; Angers: Francois, Hunault,
Ifrah, Marie, Genevieve, Baranger, Chassevent, Blanchet; Avignon: Boulat, Derre; Bayonne: Banos, Bauduer, Burtin; Bobigny: Gardin, Fenaux, Beve, Boulalam, Eclache, Fenaux; Bordeaux: Boiron,
Leguay, Pigneux, Bilhou-Nabera, Perry, Lacombe, Tabrizi, Lippert, Marit; Brest: Guillerme, Berthou, Lecalvez, De Braekeleer, Ugo; Caen: Reman, Lepesant, Salaun, Plessis, Naguib, Leporrier;
Clamart: De Revel, Samson, Desangles; Clermont-Ferrand: Chaleteix, Villemagne, Latiere, Berger, Giollant, Tchirkov, Tournilhac; Dijon: Caillot, Casanovas, Grandjean, Menadier, Favre-Audry,
Mugneret, Teyssier; Lens: Stalnikiewicz, Poulain; Lille: Darre, De Botton, Lepelley, Lai, Soenen, Preudhomme, Grardel, Bauters; Limoges: Turlure, Bordessoule, Chaury, Trimoreau, Gachard;
Lyon: Le, Nicolini, Tavernier, Thiebaut, Thomas, Lheritier, Girard, Wattel, Tigaud, Hayette, Michallet; Marseille: Vey, Charbonnier, Stoppa, Mouton, Sainty, Moziconacci, Arnoulet,
Lafage-Pochitaloff, Blaise; Meaux: Frayfer, Mossafa; Mulhouse: Arkam, Ojeda Uribe, Iglarz, Drenou, Jeandidier, Isaac; Nancy: Witz, Bene, Witz, Gregoire, Monhoven; Necker: Buzyn, Couderc,
Asnafi, Valensi, Radford-Weiss, Delabesse, Macintyre, Varet; Paris Pitié-Salpétrière: Dhedin, Aliammar, Merle-Beral, Nguyen-Khac, Davi, Leblond, Vernant; Paris Saint-Louis: Raffoux,
Treilhou, Maarek, Daniel, Soulier, Cayuela, Miclea, de Labarthe, Dombret; Reims: Himberlin, Baury, Daliphard, Luquet, Cornillet-Lefebvre, Delmer; Rennes: Escoffre-Barbe, Lamy, Picouleau,
Roussel, Henry, Ly Sunnaram, Fest; Rouen: Lepretre, Contentin, Jardin, Lenain, Tilly, Tallon, Lenormand, Stamatoullas-Bastard, Penther, Bastard; Saint-Etienne: Cornillon, Jaubert, Guyotat,
Marchand, Campos, Nadal, Flandrin; Toulon: De Jaurreguiberry; Toulouse: Huguet, Recher, Daniel, Kuhlein, Dastugue, Demas, Attal; Tours: Delain, Delepine, Degene, Barin, Colombat;
Valenciennes: Fernandes, Poulain, Daudignon; Versailles: Choquet, Rousselot, Taksin, Pousset, Terre, Castaigne; Villejuif: Arnaud, Bayle, Bourhis, Auger, Bernheim. Among these participants,
we specially acknowledge the following cytogeneticists that provided cytogenetic pellets and data to perform _PAX5_ and _TCF3_ FISH analyses, Eric Lippert (Bordeaux), Odile Maarek (Paris
Saint-Louis), Christian Bastard and Dominique Penther (Rouen), Isabelle Tigaud (Lyon), Florence Nguyen-Khac (Paris Pitié-Salpétrière), Christine Terré (Versailles) and Ghislaine Plessis
(Caen). We thank the extended FISH analysis of Francesca Correia (Toulouse). The design and analysis of the experiments were performed by ED and CB. JF performed the PAX5 quantitative PCR.
MB cloned and analyzed the PAX5-ELN case. They cloned the PAX5 mutants helped by ND, SS, EC, CQ, NPH and SD. ED, CB and PB overviewed the results. The cytogenetic results were collected and
analyzed by MLP and ND. FISH analyses were performed by MLP and CB. The immunophenotype results were collected by MCB. The molecular data were collected by EAM and ED. KB performed VHDHJH
sequence analysis. JDV performed the microarray analysis. JMC, NG, CP, HC, OB, KB and EAM provided DNA samples. VL collected clinical data, reviewed by YC, NI, AD, AP, FH and HD. Paper was
written by ED, CB, JF and HD. AUTHOR INFORMATION Author notes * J Familiades, M Bousquet, C Broccardo and É Delabesse: J Familiades and M Bousquet contributed equally to this work as first
authors; C Broccardo and É Delabesse contributed equally to this work as senior authors. AUTHORS AND AFFILIATIONS * INSERM U563, Toulouse, France J Familiades, M Bousquet, N Dastugue, E
Coyaud, C Quelen, N Prade-Houdellier, P Brousset, C Broccardo & É Delabesse * Centre de Physiopathologie Toulouse Purpan, Université Toulouse III Paul Sabatier, Toulouse, France J
Familiades, M Bousquet, E Coyaud, C Quelen, N Prade-Houdellier, P Brousset, C Broccardo & É Delabesse * Department of Genetics, CHU Timone, Marseilles, France M Lafage-Pochitaloff *
Department of Immunology, CHU Nancy, Nancy, France M-C Béné * Department of Hematology, CHU Necker, Paris, France K Beldjord & E A Macintyre * INSERM U847, Montpellier, France J De Vos *
Biothérapie des cellules souches normales et cancéreuses, Université Montpellier I, Montpellier, France J De Vos * Department of Hematology, CHU Toulouse, Toulouse, France N Dastugue, S
Struski, S Dobbelstein, F Huguet & É Delabesse * Department of Hematology, CHU Saint-Louis, Paris, France J-M Cayuela, J Soulier & H Dombret * Department of Hematology, CHU Lille,
Lille, France N Grardel & C Preudhomme * Department of Genetics, CHU Robert-Debré, Paris, France H Cavé * Department of Hematology, CHU Angers, Angers, France O Blanchet & N Ifrah *
GRAALL, CHU Lyon, Lyons, France V Lhéritier * Department of Hematology, Cliniques Universitaires Saint-Luc, Brussels, Belgium A Delannoy * Division of Hematology, Hôpital Universitaire,
Geneva, Switzerland Y Chalandon * Department of Hematology, CHU Bordeaux, Bordeaux, France A Pigneux * Department of Pathology, CHU Toulouse, Toulouse, France P Brousset Authors * J
Familiades View author publications You can also search for this author inPubMed Google Scholar * M Bousquet View author publications You can also search for this author inPubMed Google
Scholar * M Lafage-Pochitaloff View author publications You can also search for this author inPubMed Google Scholar * M-C Béné View author publications You can also search for this author
inPubMed Google Scholar * K Beldjord View author publications You can also search for this author inPubMed Google Scholar * J De Vos View author publications You can also search for this
author inPubMed Google Scholar * N Dastugue View author publications You can also search for this author inPubMed Google Scholar * E Coyaud View author publications You can also search for
this author inPubMed Google Scholar * S Struski View author publications You can also search for this author inPubMed Google Scholar * C Quelen View author publications You can also search
for this author inPubMed Google Scholar * N Prade-Houdellier View author publications You can also search for this author inPubMed Google Scholar * S Dobbelstein View author publications You
can also search for this author inPubMed Google Scholar * J-M Cayuela View author publications You can also search for this author inPubMed Google Scholar * J Soulier View author
publications You can also search for this author inPubMed Google Scholar * N Grardel View author publications You can also search for this author inPubMed Google Scholar * C Preudhomme View
author publications You can also search for this author inPubMed Google Scholar * H Cavé View author publications You can also search for this author inPubMed Google Scholar * O Blanchet
View author publications You can also search for this author inPubMed Google Scholar * V Lhéritier View author publications You can also search for this author inPubMed Google Scholar * A
Delannoy View author publications You can also search for this author inPubMed Google Scholar * Y Chalandon View author publications You can also search for this author inPubMed Google
Scholar * N Ifrah View author publications You can also search for this author inPubMed Google Scholar * A Pigneux View author publications You can also search for this author inPubMed
Google Scholar * P Brousset View author publications You can also search for this author inPubMed Google Scholar * E A Macintyre View author publications You can also search for this author
inPubMed Google Scholar * F Huguet View author publications You can also search for this author inPubMed Google Scholar * H Dombret View author publications You can also search for this
author inPubMed Google Scholar * C Broccardo View author publications You can also search for this author inPubMed Google Scholar * É Delabesse View author publications You can also search
for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to É Delabesse. ADDITIONAL INFORMATION Supplementary Information accompanies the paper on the Leukemia website
(http://www.nature.com/leu) SUPPLEMENTARY INFORMATION SUPPLEMENTARY FIGURE 1 (JPG 1114 KB) SUPPLEMENTARY FIGURE 2 (JPG 1480 KB) SUPPLEMENTARY FIGURE 3 (JPG 1664 KB) SUPPLEMENTARY TABLE S1
(JPG 2920 KB) SUPPLEMENTARY TABLE S2 (JPG 2587 KB) SUPPLEMENTARY TABLE S3 (JPG 818 KB) SUPPLEMENTARY TABLE S4 (JPG 1259 KB) SUPPLEMENTARY TABLE S5 (JPG 3008 KB) SUPPLEMENTARY TABLE 1 AND
FIGURE S5 (DOC 31 KB) RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Familiades, J., Bousquet, M., Lafage-Pochitaloff, M. _et al._ _PAX5_ mutations
occur frequently in adult B-cell progenitor acute lymphoblastic leukemia and _PAX5_ haploinsufficiency is associated with _BCR-ABL1_ and _TCF3-PBX1_ fusion genes: a GRAALL study. _Leukemia_
23, 1989–1998 (2009). https://doi.org/10.1038/leu.2009.135 Download citation * Received: 04 September 2008 * Revised: 17 March 2009 * Accepted: 05 May 2009 * Published: 09 July 2009 * Issue
Date: November 2009 * DOI: https://doi.org/10.1038/leu.2009.135 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a
shareable link is not currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * BCP-ALL * oncogenesis * BCR-ABL1
* PAX5 * TCF3-PBX1